Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The short half-life of glucagon-like peptide-1 in plasma does not reflect its long-lasting beneficial effects
That means the FDA doesnt review them for safety or effectiveness before theyre sold
Just over half (56%) of GLP-1 users including 55% of those with health insurance say it was difficult to afford these drugs, including one in four who say it was very difficult. The cost of the medications as well as side effects are the most common reason given for discontinuing GLP-1 use
Your healthcare provider at PlexusDx will help you follow the evidence-based dosing timeline to maximize safety and effectiveness
US$ 21.92
US$ 29.96
US$ 29.73
US$ 23.96
US$ 28.08
US$ 23.80
US$ 29.95
US$ 28.81
